logo
Top Stories
56
45
Uber-Fine-112117-lg.jpg

Uber has been hit with an $8.9 million civil penalty by Colorado for allegedly allowing drivers with questionable backgrounds to work for the ride-hailing company. The Colorado Public Utilities Commission or PUC said it has issued a Civil Penalty Assessment...

Ibovespa, the benchmark stock market index in Brazil, closed up 1.57% at 74,594.61 points on Tuesday amid a better external scene and investors' view that president Michel Temer is closer to get the pension reform bill voted in the House of Representatives...

AjitVPai-112117-lg.jpg

Federal Communications Commission Chairman Ajit Pai has announced plans to repeal the net neutrality rules implemented under President Barack Obama. Pai, who was appointed by President Donald Trump, said he circulated his draft order to his fellow...

Asian-Markets1_21Nov17.jpg

Asian stock markets are in positive territory on Wednesday following the fresh record closing highs overnight on Wall Street with investor sentiment boosted by upbeat corporate earnings results and higher commodity prices.

CharlieRose-GlennThrush-112117-lg.jpg

Two prominent media personalities were fired by their parent organizations over sexual misconduct allegations. Famous talk show host Charlie Rose and The New York Times' White House reporter Glenn Thrush were at the receiving end. CBS News, PBS...

stocklower-111517.jpg European stocks may open on a subdued note on Wednesday as investors keep an eye on oil price movements and the upcoming vote on the U.S Republican tax reform bill. House Speaker Paul Ryan on Tuesday described the current plans as a "work in progress"...
Pharma-111517.jpg Today's Daily Dose brings you news about Apollo Medical's fiscal 2018 second quarter financial results; FDA approval of AstraZeneca's asthma drug; EyeGate's upcoming clinical trial catalysts; Genmab's revised revenue outlook and Pacira's update on its EXPAREL sNDA.
KplusSgroup-111517.jpg Potash maker K+S Group reported Wednesday a profit in its third quarter, compared to loss last year, and EBITDA climbed 37 percent. Revenues were benefited by improved results in Potash and Magnesium Products segment, partly offset by weak salt revenues. Further, the company reiterated its fiscal 2017 forecast, expecting a tangible increase.
stocklower2-111517.jpg Asian stocks fell broadly on Wednesday as commodities declined on concerns over slowing growth in China and uncertainty prevailed over the fate of a U.S. tax reform bill. Chinese shares extended losses after a slew of data released on Tuesday suggested...
More
Putin-Trump-112117.jpg President Donald Trump spoke by phone Tuesday with Russian President Vladimir Putin to discuss various international hot spots, including Syria and North Korea. The call came a day after Putin met with Syrian President Bashar al-Assad to discuss the...
More
DC-Office-112117.jpg Reflecting expectations the House Republican tax reform bill would provide a relatively modest boost to economic growth, a new analysis by the Tax Policy Center found that the legislation would add about $1.3 trillion to the national debt over a decade.
More
BillGates-CuringAlzheimers-111317.jpg
Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
More
Indian shares look set to open higher on Wednesday, tracking firm global markets and sharp gains in rupee the previous day in the face of Moody's decision last week to upgrade India's sovereign rating after a gap of 14 years. Benchmark indexes Sensex and the Nifty rose for the fourth consecutive...
Uber-Fine-112117.jpg
Uber has been hit with an $8.9 million civil penalty by Colorado for allegedly allowing drivers with questionable backgrounds to work for the ride-hailing company. The Colorado Public Utilities Commission or PUC said it has issued a Civil Penalty Assessment Notice or CPAN totaling $8.9 million to Rasier LLC, the parent company of Uber.
More
Today's Daily Dose brings you news about Aerie's progress in phase II trial of glaucoma drug in Japan; phase III results of Egalet's pain pill; FDA approval of GlaxoSmithKline's COPD drug; expanded labeling for Pfizer's kidney cancer drug Sutent and Roche's double blessing on Thursday. More
The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of November 21, 2017. More
Zimbabwe's leader Robert Mugabe has vowed to stay in power for several weeks, despite intensifying pressure on him to stand down, according to reports. In a live TV address, Mr Mugabe said he would preside over the ruling party's congress in December. The...
More
Uber-Fine-112117.jpg Uber has been hit with an $8.9 million civil penalty by Colorado for allegedly allowing drivers with questionable backgrounds to work for the ride-hailing company. The Colorado Public Utilities Commission or PUC said it has issued a Civil Penalty Assessment Notice or CPAN totaling $8.9 million to Rasier LLC, the parent company of Uber.
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
11/21/17 19:30Consruction Work DoneQ3 Australia
11/21/17 18:30Westpac Leading Index (M-o-M)OCT Australia
11/21/17 10:0Existing Home Sales - InventoriesOCT United States
11/21/17 10:0Existing Home Sales - SalesOCT United States
11/21/17 10:0Existing Home Sales - PriceOCT United States
11/21/17 9:30CB Coincidence IndexOCT Eurozone
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
Complete FDA Calendar
>>
More